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Abstract
Background:  The  prevalence  of  pediatric  urolithiasis  varies  from  0.01--0.03%.  Urolithiasis  may
be caused  by  anatomical,  metabolic  and  environmental  factors.  Recurrence  varies  between
16 to  67%,  and  it  is  frequently  associated  with  metabolic  abnormalities.  The  objective  of  the
present work  was  the  identiﬁcation  of  risk  factors  that  promote  urolithiasis  in  a  child  population.
Methods:  This  study  included  162  children  with  urolithiasis  and  normal  renal  function  (mean
age 7.5  years).  Risk  factors  were  investigated  in  two  stages.  In  the  ﬁrst  stage,  24-hour  urine,  and
blood samples  were  analyzed  to  assess  metabolic  parameters  and  urinary  tract  infection.  During
the second  stage,  the  effect  of  calcium  restriction  and  a  calcium  load  on  renal  Ca  excretion
were evaluated.  Data  were  statistically  analyzed.
Results:  Urolithiasis  was  observed  in  0.02%  of  children,  50%  of  them  with  family  history  of  uri-
nary stones.  There  were  multiple  risk  factors  for  urolithiasis  including  hypocitraturia  (70%),
hypomagnesuria  (42%),  hypercalciuria  (37%;  in  11/102  was  by  intestinal  hyperabsorption,  in
13/102 was  unclassiﬁed.  Ca  resorption  or  renal  Ca  leak  were  not  detected).  We  also  detected
alkaline urine  (21%),  systemic  metabolic  acidosis  (20%),  urinary  infections  (16%),  nephrocal-
cinosis with  urolithiasis  (11%),  oliguria  (8%),  urinary  tract  anomalies,  hyperuricosemia  and
hypermagnesemia  (7%  each  one),  hypercalcemia  (6%),  hyperoxaluria  (2%)  and  hypercystinuria
(0.61%).
Conclusions:  Hypocitraturia  and  hypomagnesuria  were  the  most  frequent  risk  factors  associ-
ated with  urolithiasis,  followed  by  hypercalciuria.  High  PTH  values  were  excluded.  Children
presented  two  or  more  risk  factors  for  urolithiasis.
© 2016  Hospital  Infantil  de  Me´xico  Federico  Go´mez.  Published  by  Masson  Doyma  Me´xico  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).∗ Corresponding author.
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Evaluación  de  factores  de  riesgo  para  urolitiasis  en  nin˜os
Resumen
Introducción:  La  prevalencia  de  urolitiasis  pediátrica  varía  de  0.01--0.03%.  Las  causas  de  uroli-
tiasis pueden  ser  anatómicas,  metabólicas  o  ambientales.  Las  recurrencias  varían  entre  16  a
67%, y  están  frecuentemente  asociadas  con  alteraciones  metabólicas.  El  objetivo  del  presente
trabajo fue  la  identiﬁcación  de  factores  de  riesgo  que  promueven  la  urolitiasis  en  una  población
infantil.
Métodos: Se  incluyeron  162  nin˜os  con  urolitiasis  y  función  renal  normal,  cuya  edad  media  fue
de 7.5  an˜os.  Los  factores  de  riesgo  fueron  investigados  en  dos  etapas.  En  la  primera,  con  la
muestras de  orina  de  24  h  y  sangre,  se  investigaron  parámetros  metabólicos  e  infecciones  del
tracto urinario.  En  una  segunda  etapa  se  valoró  la  calciuria,  previa  restricción  seguida  de  carga
de Ca.  Los  hallazgos  fueron  analizados  estadísticamente.
Resultados:  Se  presentó  urolitiasis  en  el  0.02%  de  los  nin˜os  con  historia  familiar  en  el  50%.
Se observó  hipocitraturia  (70%);  hipomagnesuria  (42%);  hipercalciuria  (37%;  en  11/102  fue  por
hiperabsorción  intestinal;  en  13/102  fue  inclasiﬁcable;  no  se  observó  hipercalciuria  por  resor-
ción o  pérdida  renal).  También  se  observó  orina  alcalina  (21%);  acidosis  metabólica  sistémica
(20%); infecciones  urinarias  (16%);  nefrocalcinosis  con  urolitiasis  (11%);  oliguria  (8%);  anomalías
urinarias congénitas,  hiperuricosemia  e  hipermagnesemia  (7%  cada  una);  hipercalcemia  (6%);
hiperoxaluria  (2%);  e  hipercistinuria  (0.61%).
Conclusiones:  La  hipocitraturia  e  hipomagnesemia  fueron  los  factores  de  riesgo  con  mayor  fre-
cuencia, seguidos  de  hipercalciuria.  Se  excluyeron  los  valores  de  hiperparatiroidismo.  Los  nin˜os
exhibieron  dos  o  más  factores  de  riesgo  para  el  desarrollo  de  urolitiasis.
© 2016  Hospital  Infantil  de  Me´xico  Federico  Go´mez.  Publicado  por  Masson  Doyma  Me´xico  S.A.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Pediatric  urinary  stone  disease  occurs  infrequently  in  devel-
oped  countries.  The  incidence  of  hospital  admission  due
to  urinary  stones  varies  from  0.01--0.03%.1,2 However,
in  the  United  States,  there  has  been  an  increase  from
18.4  cases  per  100,000  hospital  admissions  in  1999  to  57
cases  per  100,000  in  2008,  with  an  adjusted  annual  increase
of  10.6%  (p  >  0.001).  Thus,  the  incidence  of  urinary  tract
stone  disease  has  increased  signiﬁcantly  among  adolescents
since  1996  during  a  25-year  period.3,4 Recurrence  varies  from
16  to  67%  and  is  more  frequently  present  in  children  with
metabolic  disorders.5 The  site  of  localization  of  the  stone
varies:  66%  of  stones  are  found  in  the  renal  parenchyma  and
the  rest  are  located  in  the  ureter,  ureterovesical-junction
and  bladder.6
Factors  that  enhance  stone  formation  include  decreased
levels  of  natural  inhibitors  of  urinary  tract  stone  formation,
such  as  citrate,  magnesium,  osteopontin,7 pyrophos-
phate  (PPi),  calgranulin,8 uromodulin,9 urokinase,10 Tamm-
Horsfall  glycoprotein  and  albumin.11 In  addition,  concen-
trated  urine  is  a  risk  factor  as  it  favors  an  increase  of
salts,  resulting  in  their  precipitation.12 Other  factors  include
anatomical  abnormalities  of  the  urinary  tract,  metabolic  dis-
orders,  urinary  tract  infections,  environment  and  low  urine
volume.Urinary  tract  stones  are  rarely  asymptomatic.  Common
symptoms  include  abdominal  pain,  hematuria  and  dysuria.
Urolithiasis  (UL)  is  observed  more  frequently  in  children  than
in  older  patients6.  A  family  history  of  urinary  tract  stones  is
t
T
dresent  in  20--37%  of  children  but  it  occurs  at  all  ages.13
tudies  suggest  that  nephrolithiasis  (NL)  is  inherited  with  a
on-Mendelian  transmission  pattern  with  multiple  genes.14
Some  studies  have  described  that  renal  stones  are  more
requent  in  males,  but  recent  studies  have  mentioned  that
emale  children  are  at  higher  risk.15 To  this  day,  more  than
8  pathogenic  factors  have  been  associated  with  the  forma-
ion  of  urinary  tract  stones;  this  number  is  increasing  and
he  frequency  changing.  Nevertheless,  more  studies  for  the
valuation  of  these  factors  in  the  pediatric  population  are
eeded.  The  purpose  of  this  study  was  to  determine  the
requency  of  urinary  tract  stones  and  the  pathogenic  fac-
ors  associated  with  their  formation  in  patients  from  the
ospital  Infantil  de  México  Federico  Gómez  (HIMFG).
.  Patients and methods
his  study  was  conducted  according  to  the  recommendations
f  the  World’s  Medical  Association  Declaration  of  Helsinki,
nd  was  approved  by  the  hospital’s  Internal  Review  Board
IRB)  and  the  Ethics  Committee.  The  IRB  considered  unwise
o  submit  children  for  the  diagnosis  of  renal  tubular  acido-
is  (RTA)  because  it  requires  the  sampling  of  arterial  blood,
either  children  <  5  years  for  dietary  calcium  (Ca)  manipu-
ation.  Parental  written  consent  and  assent  of  the  patient
ere  obtained  in  all  cases.
Our  data  included  775,230  children  evaluated  from  2009
o  2014,  admitted  to  the  hospital  outpatient  department.
he  pediatricians  in  our  urology-nephrology  clinic  initially
iagnosed  urinary  tract  stones  in  170  children  <  17  years
230  F.  Velásquez-Forero  et  al.
Table  1  Comparison  of  controls  vs.  patients  results  of  selected  stone-forming  risk  factors.
Blood  (mg/dl)  Control
(N  =  170)
Patients
(N  =  162)
p  value
Ca  9.53  ±  0.68  11.07  ±  0.50  (10)  <  0.001
Mg 2.14  ±  0.31  1.24  ±  0.37  (11)  <  0.001
P 4.11  ±  0.96  4.67  ±  1.22  (162)  <  0.001*
Creatinine  0.67  ±  0.30  0.68  ±  0.27  (162)  >  0.8
Uric acid  4.0  ±  5.8  7.83  ±  1.06  (11)  <  0.001
Albumin 4.4  ±  0.53  2.3  ±  2.4  (21)  <  0.001
PTH (pg/ml)  33.94  ±  12.70  21.0  ±  13.3  (162)  <  0.001*
Urine  (24  h)
Citrates  (mg/24  h) 512.66  ±  183.09 204.33  ±  81.13  (113) <  0.001
Mg (mg/24  h) 87.64  ±  35.12 23.34  ±  10.55  (70) <  0.001
UCa/BM(mgCa/kg/24  h)  (NV  ≤  4  mg/kg/24h)19,20 6.06  ±  2.01  (60)  <  0.001
P (mg/24  h)  651.38  ±  255.84  576.88  ±  116.62  (162)  <  0.001*
Creatinine  (mg/24  h)  673.27  ±  655.31  109.2  ±  59.9  (162)  <  0.001*
Uric  acid  (mg/24  h)  96.04  ±  102.94  141.53  ±  77.92  (162)  <  0.001*
Oxalates  (mg/24  h)  15.65  ±  11.58  57.19  ±  6.51  (3)  <  0.001
Values were expressed as mean ± SD (n).
PTH, parathyroid hormone; UCa/BM, urinary calcium-body mass relation; NV, normal values.
* Signiﬁcant difference but no clinical abnormality (data levels in each children were within the normal range).
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•f  age  (mean  age  7.5  ±  3.9  years)  who  were  selected  to
erform  this  study  following  the  exams  according  to  the
esearch  protocol.
Control  subjects  (170)  were  also  evaluated  during  this
eriod  (2009--2014).  Medical  charts  were  reviewed,  fam-
ly  history  analyzed,  and  laboratory  data  collected.  Control
ubjects  with  normal  renal  function  had  a  mean  age  of
.0  ±  4.7  years.  Fifty-two  of  them  (30%)  underwent  abdom-
nal  ultrasound  and  no  UL  was  found.  Blood  and  urinary
iochemical  studies  were  performed  and  all  results  were
ithin  normal  levels.  Data  of  patients  with  urinary  tract
tones  as  compared  with  controls  are  included  in  Table  1.
.1.  Classiﬁcation  criteria
s  NL  is  multifactorial  in  origin  in  each  children,  a  minimum
cheme  diagnostic  criteria  was  used  as  follows:
Patients  (170)  were  evaluated  for  urogenital  abnor-
alities,  back  pain,  hematuria,  and  recurrent  urinary
ract  infections,  conﬁrming  the  diagnosis  by  ultrasound,
lain  abdominal  X-rays  and  the  spontaneous  expulsion  of
tones.  They  all  resided  in  Mexico  City  and  the  surrounding
etropolitan  area.  A  detailed  family  history  suggestive  of  UL
as  obtained.  The  effect  of  Ca  manipulation  was  evaluated
nly  in  children  >  5  years.  Children  with  abnormal  renal  func-
ion  or  receiving  therapy  that  altered  Ca,  phosphorous  (P),
agnesium  (Mg),  uric  acid  (UA),  oxalates,  or  vitamin  D  were
xcluded.  Patient  nutrition  was  evaluated  via  Z-scores  from
ody  mass  index  (BMI),  considering  the  following  ranges:
ormal  >  −1  to  <  +  1;  low  ≤  −1;  overweight  ≥  +  1  to  <  +  2;
nd  obese  ≥  +  2.16An  ambulatory  protocol  divided  into  two  stages  was  fol-
owed:
The  ﬁrst  stage  (basal  data)  included  two  24-hour  urine
amples  and  one  blood  sample  collection.  For  urine,  volume,a,  oxalates,  Mg,  uric  acid,  Na,  K,  Cl,  citrates,  P,  creatinine,
nd  cystine  levels  were  quantiﬁed  and  urine  samples  were
ultured.  Venous  blood  samples  were  analyzed  for  parathy-
oid  hormone  ‘‘intact’’  molecule  (PTHi),  HCO3, PCO2 and
H,  creatinine,  Cl,  Ca,  P,  Mg,  uric  acid,  albumin  and  creati-
ine  clearance.17,18
The  second  stage  included  a  period  of  Ca  restriction,  a
asting  urinary  sample  and  another  sample  of  Ca  load  in
02  children  >  5  years.  The  analyses  were  designed  to
nvestigate  the  origin  of  hypercalciuria  with  an  indirect
ssessment  of  renal  handling  of  Ca  after  a  period  of  dietary
a  restriction  and  after  a  diet  Ca  load  to  categorize  the
ypercalciuria  into  absorptive,  resorptive,  renal  or  unclassi-
ed  form.18 Dietary  Ca  restriction  phase  consisted  of  a  daily
educed  Ca  diet  (50%)  for  7--10  days.  On  the  last  day,  venous
lood  and  urine  samples  were  collected  to  test  the  levels  of
a  and  Pi  in  urine,  and  Ca,  P and  PTH  in  blood.17,18
Parameters  were  classiﬁed  as  follows:
 Calciuria.  Normal  levels  of  urinary  Ca  were  obtained
from  international  data  for  children  (normal  values  ≤4  mg
Ca/kg/24  h).19,20 Ca  levels  were  measured  in  controls  and
patients  with  anatomic  absorption  spectrophotometry.
--  Renal  hypercalciuria.  A  ‘‘fasting  urinary  sample’’
was  obtained  from  children  with  hypercalciuria  on  a
restricted  diet  2 h  after  the  end  of  the  Ca  restriction
phase.  Abnormal  fasting  urinary  Ca  on  the  restricted
diet  is  deﬁned  by  UCa  x  SCr/UCr  ≥  0.11  mg/Ca/dlGF
(where  UCa  stands  for  urinary  Ca,  SCr  for  serum  cre-
atinine,  and  UCr  for  urinary  creatinine  in  mg/dl  of
glomerular  ﬁltrate),  accompanied  by  normocalcemia,
normophosphatemia  and  elevated  serum  PTH.  In  this
situation,  a  restricted  renal  tubular  reabsorption  of
calcium  is  suggested.18
--  Absorptive  hypercalciuria  (dietary  Ca  load  phase).
Patients  with  hypercalciuria  after  Ca  restricted  diet,
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with  normal  ‘‘fasting  urinary  Ca’’  (<  0.11  mg/dlGF)
were  administered  1  g  of  Ca  (2  tablets,  500  mg  each
one).  Four  hours  later,  a  urine  sample  was  obtained  for
UCa  and  UCr  levels  measurement.  An  increase  in  uri-
nary  Ca  after  the  Ca  load  is  deﬁned  by  UCa/UCr  ≥  0.20
mgCa/mg  creatinine,  accompanied  by  normocalcemia,
normophosphatemia,  and  normal  PTH.  An  increased
calcium  intestinal  absorption  is  suggested.18
--  Resorptive  hypercalciuria.  It  occurs  if  an  increased
bone  turnover  leads  to  urinary  loss  of  bone  Ca  by
primary  hyperparathyroidism.  Hypercalcemia,  hyper-
calciuria  and  high  serum  levels  of  PTH  are  present.17,18
-- Unclassiﬁed  hypercalciuria.  Hypercalciuria  on  the
restricted  diet  that  cannot  be  categorized  into  absorp-
tive,  resorptive  or  renal  form  is  considered  as
unclassiﬁed.18
•  Hypocitraturia.  Urinary  citrate  was  measured  with  a
commercial  kit  (Boehringer  Mannheim,  Indianapolis,
USA),  based  on  citric  conversion  to  oxaloacetate  and
the  liberation  of  NADH  +  H,  which  is  equivalent  to  the
amount  of  citrate21 (normal  levels  from  the  controls  were
≥  306  mg/24  h).
•  Hypomagnesuria.  Urinary  Mg  was  measured  using  an
atomic  absorption  spectrophotometry.  Hypomagnesuria  is
determined  by  levels  <  50  mg/d  on  a  random  diet,  and  the
absence  of  a  gastrointestinal  disorder.22
•  Systemic  metabolic  acidosis.  It  was  determined  with  a
gasometer  (GEM  Premier  3000),  recognized  by  the  co-
occurrence  of  blood  acidemia  (pH  <  7.40,  low  serum  bicar-
bonate  concentration  <  20  mEq/l  and  PCO2 >  34  mmHg
in  children  <  2  years.  For  children  >  2  years,  values
are  pH  <  7.39,  low  serum  bicarbonate  concentration  <  22
mEq/l  and  PCO2 >  37  mmHg).23
•  Low  urinary  volume.  Urinary  samples  were  assessed  for
volume  in  ml/m2 (oliguria  ≤  300  ml/m2 per  24  h).24
•  Urinary  pH.  Urinary  pH  is  simple  a  measure  of  free  H+ ions
in  urine.  It  was  measured  with  an  electrode:  pH  values  ≥
6.5  for  alkaline  urine,  and  pH  ≤  5.518  for  acid  urine.
•  Hyperuricosuria.  Hyperuricosuria  is  deﬁned  as  the  urinary
excretion  of  uric  acid  >  600  mg/d  (measured  by  enzymatic
spectrophotometry  procedures),  and  urinary  pH  ≥  5.5.18
•  Hyperoxaluria.  It  was  determined  with  an  oxalate  kit  pur-
chased  from  Trinity  Biotech  (Berkeley  Heights,  NJ)  based
on  the  oxidation  of  oxalate  by  oxalate  oxidase,  followed
by  the  measurement  of  hydrogen  peroxide  by  oxalate
oxidase  and  a  peroxidase-catalyzed  reaction  (hyperox-
aluria  >  45  mg/d).25,26
•  Nephrocalcinosis  (NC)  and  renal  calculi.  The  presence  of
calciﬁcations  in  the  renal  parenchyma  (NC)  or  located
within  the  collecting  system  (UL)  were  identiﬁed  by  ultra-
sound  or  X-ray.  NC  and  UL  may  occur  simultaneously  or
individually.  NC  can  be  diagnosed  mainly  when  increased
echogenicity  appears  in  the  renal  medulla.27,28 Familial
hypomagnesemia  with  hypercalciuria  and  nephrocalci-
nosis  is  an  autosomal  recessive  tissue  disorder.
•  Urinary  tract  infection.  Chronic  urinary  tract  infec-
tion  may  be  associated  with  urease-production  bacteria,
resulting  in  alkaline  urine,  and  stones  composed  of  Mg,
ammonium  and  phosphates  (struvite  stones).29
•  Urinary  cystine.  It  was  detected  by  Sullivan  test,  with
sodium  cyanide-naphto-quinone-1-sulfonate  (normal  val-
ues:  >60  mg/1.73/m2/day).30
P
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.2.  Analytical  methods
rinary  Na  and  K levels  were  measured  by  ﬂame  photometry,
nd  Cl  was  determined  by  colorimetric  silver  precipita-
ion.  Albumin  was  detected  using  the  bromocresol  green
ethod  (normal  values:  3.5--5.0  g/dl).31 The  glomerular
ltration  rate  (GFR)  was  estimated  by  Schwartz  formula
s  follows:  eGFR/ml/min  1.73  m2 =  kL/SCr  (mg/dl),  where
 is  a  constant  value  (0.55  for  children  and  adolescent
irls,  and  0.7  for  adolescent  boys),  L  is  the  length  in
m,  and  SCr  is  the  serum  creatinine  levels  (normal  val-
es:  >  60  ml/min/1.73  m2).32
PTHi  (normal  values:  15.18--53.4  pg/ml)  was  assessed  by
adioimmunoassay  after  labeling  with  I125 (DiaSorin,  Inc.,
tillwater,  MN,  USA)33.  Other  reagents  were  obtained  from
ocal  distributors.
.3.  Statistical  analysis
ata  from  control  children  were  analyzed  to  obtain  ref-
rence  values  for  biochemical  parameters.  Means  and
tandard  deviations  were  calculated  to  ﬁx  the  cut-off  points
hat  deﬁned  the  abnormal  values.  Subsequently,  patients
nd  controls  results  were  compared  using  the  Student’s  t-
est  and  Fisher’s  exact  test  with  a  5%  of  signiﬁcance  level34.
ll  data  were  analyzed  using  SPSS  version  18.0.
.  Results
uring  a 5-year  period  (2009--2014),  775,230  children  were
dmitted  to  the  HIMFG  outpatient  department.  The  urol-
gy/nephrology  team  detected  the  presence  of  UL  in
70  children.  Thus,  the  frequency  of  UL  in  a  5-year  period
as  0.02%  (1/4560  consults).  From  this  group,  eight  chil-
ren  were  excluded  because  the  lack  of  compliance.  Finally,
62  children  with  a  mean  age  of  7.5  years,  ranging  from  6
onths  to  17  years  were  included  in  the  study.  Sixty  chil-
ren  were  <  5  years  and  102  children  were  >  5  years.  There
ere  127  male  (78%),  and  the  gender  ratio  male/female  was
:1.  A  family  history  of  calculi  in  ﬁrst  and  second-degree
elatives  was  present  in  49.6%.  The  mean  serum  creatinine
evel  was  0.70  ±  0.3  mg/dl,  and  the  mean  creatinine  clear-
nce  was  109.2  ±  59.9  ml/min/1.73  m2.  The  BMI  (children
-score)  was  normal  in  55%,  low  in  27%,  overweight  in  13%
nd  obesity  in  5%  of  the  children.
Clinical  symptoms  included  abdominal  pain  (52%),  hema-
uria  (36%),  urinary  tract  infection  (22%)  and  dysuria  (18%).
he  diagnosis  of  UL  was  conﬁrmed  by  renal  ultrasonogra-
hy  in  60%,  by  spontaneous  expulsion  in  30%,  and  by  plain
bdominal  X-ray  in  10%.  The  distribution  of  the  stones  was
yelocaliceal  (52%),  ureteral  (7%),  bladder  (8%),  or  urethra
3%).
Table  1  includes  basal  serum  and  urinary  values  from  the
62  patients  as  compared  with  controls.  Signiﬁcant  changes
p  <  0.001)  were  observed  for  serum  Ca  in  10  patients;  for
erum  uric  acid,  and  Mg  levels  in  11  patients,  as  well  as
or  albumin  in  21  subjects.  P,  creatinine  and  basal  serum
THi  levels  were  within  the  normal  levels.  In  urine,  we
bserved  low  citrate  levels  in  113  children;  low  Mg  levels
n  70  children;  hypercalciuria  in  60  patients,  and  signiﬁcant
yperoxaluria  in  three  patients.  Children  with  normal  renal
232  
Table  2  Main  risk  factors  for  urolithiasis  observed  in  chil-
dren (N  =  162).
N  %
Hypocitraturia  113  70
Hypomagnesuria  70  43
Hypercalciuria  60  37
Ca intestinal  hyperabsorption
(102  children  >  5  years)
11  11
Unclassiﬁed  hypercalciuria
(102  children  >  5  years)
13  13
Alkaline  urine  34  21
Acid urine  33  20
Systemic  metabolic  acidosis  33  20
Urinary  tract  infection  26  16
Nephrocalcinosis  with  urolithiasis  18  11
Oliguria  14  8
Congenital  urinary  malformations  11  7
Hyperuricosemia  11  7
Hypomagnesemia  11  7
Basal hypercalcemia  10  6
Hyperoxaluria  3  2
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Obesity,  a  risk  factor  recently  associated  with  NL37,  wasHypercystinuria  1  0.61
unction  (170)  or  lithiasis  (162)  results  exhibited  signiﬁcant
ifferences  in  blood  (P  and  PTHi)  and  urine  samples  (P,  cre-
tinine  and  uric  acid),  but  each  one  presented  laboratory
alues  and  clinical  behavior  within  the  normal  limits.
The  frequency  of  the  main  risk  factors  was  observed  as
ollows:  hypocitraturia  in  70%,  hypomagnesuria  in  43%,  and
ypercalciuria  in  37%.  Alkaline  urine  was  present  in  21%
f  the  patients;  acid  urine  in  20%  and  systemic  metabolic
cidosis  in  33  children  (10  children  <  2  years  and  23  chil-
ren  >  2  years).  Urinary  tract  infection  (UTI)  was  noticed
n  26/162  children  (16%)  (Table  2).  Fourteen  children
ad  positive  urine  cultures  for  E.  coli  and  Staphylococ-
us  aureus,  and  12  children  for  Proteus  sp,  Klebsiella  sp,
nd  Pseudomonas  aeruginosa. UL  with  NC  was  noted  by
ltrasound  and  with  plain  abdominal  X-rays  in  18  children
11%)  (Table  2),  from  which  none  presented  hypomagnes-
mia  with  hypercalciuria  and  NC  (Table  3).  Ca  deposits
ere  predominantly  localized  in  the  medullary  region  and
he  stones  in  the  collecting  tubes.  Oliguria  was  noticed
o
t
p
Table  3  Serum  and  urinary  parameters  in  children  with  nephroca
Nephrocalcinosis
Serum  Ca  (mg/dl)  9.3  ±  1.19  
Serum P  (mg/dl)  4.3  ±  0.68  
Serum albumin  (mg/dl)  4.4  ±  0.53  
Serum  PTH  (pg/dl)  16.6  ±  9.7  
UCa/BM (mgCa/kg/24  h)  2.0  ±  1.73  
Citric acid  (mg/24  h)  148.2  ±  112.3  
Urinary pH  6.3  ±  1.21  
Hypomagnesemia  with  hypercalciuria  none  
Premature children  No  history  
PTH, parathyroid hormone; UCa/BM, urinary calcium-body mass relatio
* Student’s t-test.F.  Velásquez-Forero  et  al.
n  8%  of  these  patients;  congenital  urinary  malformations,
yperuricosemia  and  hypomagnesemia  in  7%  each;  basal
ypercalcemia  in  6%;  hyperoxaluria  in  2%;  and  hypercystin-
ria  in  0.61%  (Table  2).
On  the  second  stage  (dietary  Ca  restriction),  102  children
ere  evaluated.  Basal  Ca,  Pi  and  PTHi  levels,  and  levels
fter  Ca  restriction  were  similar.  Basal  hypercalciuria  was
bserved  in  46/102  (45%)  from  which  20  patients  (19.6%)
ersisted  with  hypercalciuria  after  Ca  restriction  (Table  4).
n  the  fasting  urinary  example  (Ca  >  0.11  mg/dl  GF),
3/102  patients  exhibited  hypercalciuria  (12.7%),  accom-
anied  by  normocalcemia,  normophosphatemia  and  normal
THi.  This  ﬁndings  suggested  an  unclassiﬁed  hypercalciuria
roup  (Tables  2  and  4).18 After  dietary  Ca  restriction  and  Ca
oad,  11/102  (10.7%)  children  >  5  years  exhibited  an  increase
n  urinary  Ca  (Ca  >  0.20  mg/mg  creatinine)  accompanied  by
ormocalcemia,  normophosphatemia  and  normal  PTHi,  sug-
esting  a  Ca  intestinal  hyperabsorption  (Tables  2  and  4).  We
id  not  identify  any  children  with  resorptive  hypercalciuria,
r  renal  hypercalciuria.  All  children  presented  at  least  two
r  more  risk  factors  for  the  urinary  tract  lithiasis.
. Discussion
his  study  examines  the  risk  factors  and  frequency  of  UL
n  patients  from  the  HIMFG  in  Mexico  City.  They  were  eval-
ated  by  the  urology  and  nephrology  division.  In  the  past,
tudies  emphasized  isolated  factors  as  the  cause  of  UL.7,8
n  the  present  study  (from  a  single  institution),  UL  fre-
uency  was  0.02%,  which  is  similar  to  those  reported  in  Spain
0.02%),  USA  (0.057%)  and  Iceland  (0.098%).1--3 In  the  present
rospective  study,  more  than  28  independent  biochemical
arameters  were  evaluated  in  children  >  over  a 5-year  period
2009--2014).  Family  history  of  NL  was  present  in  50%  of  our
ases,  similar  to  the  percentage  reported  by  Noe,  et  al.
50%)35 and  lower  than  those  reported  by  Polito,  et  al.
73%),36 and  Spivacow,  et  al.  (79%).6 There  were  127  males
nd  35  females.  Male/female  ratio  was  3:1;  other  reports
ave  shown  that  females  seem  to  be  at  a  higher  risk.15 It
emains  unclear  whether  gender  is  a  risk  factor  or  not.bserved  in  5%  of  the  children.  A  tendency  to  the  forma-
ion  of  uric  acid  stones  is  reported  to  be  increasing  in  obese
eople  (metabolic  syndrome).38
lcinosis  compared  to  those  with  urolithiasis.
 (n  =  18)  Urolithiasis(n  =  162)  p
9.24  ±  0.68  0.73
4.8  ±  1.20  0.013
2.3  ±  2.4  <  0.001*
18.3  ±  11.7  0.61
2.6  ±  2.6  0.35
217.02  ±  319.8  0.96
6.3  ±  0.92  0.09
2
4
n.
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Table  4  Ca  restriction  biochemical  basal  values  in  fasting  urinary  and  after  Ca  load  in  102  children  >  5  years.
Serum  basal  levels  After  Ca  restriction  p
Ca  9.18  ±  0.80  9.22  ±  0.82  0.3
P 4.68  ±  1.20  4.44  ±  1.24  1.2
PTHi 17.6  ±  10.5  18.3  ±  11.7  0.5
Urine basal  levels  (N  =  102)
n (%)
After  Ca  restriction
n (%)
Basal  hypercalciuria 46  (45%) 20  (19.6)
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aFasting hypercalciuria  (>0.11  mg/dlFG)
Hypercalciuria  in  loaded  Ca  (>20  mgCa/mgUCr)
Hypocitraturia  was  the  most  frequent  biochemical  risk
factor  identiﬁed  in  70%  of  our  children  (Table  2).  Citrate
is  the  most  abundant  organic  anion  found  in  the  urine,  as
well  as  an  important  endogenous  inhibitor  of  calcium  NL
because  it  binds  ionized  calcium  and  reduces  calcium  satura-
tion  preventing  the  growth  of  calcium  phosphate  crystals.39
Some  studies  show  that  males  present  a  lower  rate  of  citrate
excretion  than  females,  and  that  citrate  excretion  rises  with
age.40 Recently,  few  authors  have  mentioned  the  presence  of
hypocitraturia  in  children  with  UL.  However,  Tefekli,  et  al.41
and  VanDervoort,  et  al.42 reported  that  hypocitraturia  is
a  predominant  risk  factor  in  children  with  UL  (61--52%).
The  main  cause  and  pathogenesis  of  hypocitraturia  is  an
increase  in  the  renal  tubular  reabsorption  of  citrates,  in
part  due  to  intracellular  acidosis  and/or  a  reduced  alka-
line  load.43 In  our  patients,  systemic  metabolic  acidosis
(20%)  and  acid  urine  (20%)  observed  may  explain  partially
the  hypocitraturia.  Urinary  citrate  deﬁciency  is  characteris-
tic  of  renal  tubular  acidosis  (RTA),  particularly  distal  RTA
(dRTA).  The  correlation  of  hypocitraturia  with  RTA44 was
not  properly  evaluated  because  samples  came  from  venous
blood.  High  animal-protein  diets  produce  more  hydrogen
ions  that  are  buffered  by  calcium  released  from  the  bone
increasing  urinary  excretion,  which  is  prone  to  cause  low
urinary  citrate  and  stones.45 Chronic  diarrhea  produces
chronic  acidosis  and  may  cause  low  urinary  citrate  and  NL.46
Hypokalemia  and  potassium  deﬁciency  decrease  urinary
citrate  probably  by  an  acid-base  effect.46 Thiazide  diuret-
ics,  often  used  to  lower  urinary  calcium,  decrease  citrate
excretion,  particularly  if  potassium  deﬁciency  is  allowed.47
Intensive  exercise  has  also  been  reported  to  cause  low
urinary  citrate.48 Chronic  renal  insufﬁciency  reduces  daily
citrate  excretion;  this  may  be  secondary  to  mild  chronic
metabolic  acidosis.46 All  children  presented  normal  renal
function.  As  mentioned  before,  many  patients  with  calcium
NL  have  low  urinary  citrate.  Although  some  of  these  individ-
uals  might  have  unrecognized  acid-base  problems  (chronic
diarrhea,  high  protein  diets,  or  incomplete  dRTA),  there
is  no  clear  reason  for  the  low  urinary  citrate  in  others,
and  the  underlying  mechanisms  are  presently  unknown.
These  individuals  are  considered  to  have  idiopathic
hypocitraturia.
Hypomagnesuria  was  present  in  70  children  (43%)
(Table  2),  mostly  associated  with  hypocitraturia.  These  data
are  important,  since  urine  magnesium  levels  are  considered
as  a  natural  protective  factor  that  inhibit  calcium  crystal
formation.6,39
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We  observed  as  well  that  basal  hypercalciuria  was
resent  in  60  children  (37%),  from  which  43  (72%)  were
ale.  This  abnormality  was  not  as  frequent  as  previously
eported  (40--50%).8,17,18 Naturally  occurring  inhibitors  of
alcium  crystal  formation,  anatomical  abnormalities,  uri-
ary  tract  infections,  environmental  factors  and  low  urinary
olume  enhance  the  formation  of  calcium  stones.  Calcium
upersaturation  is  strongly  linked  to  high  urinary  calcium
xcretion.39 Most  urinary  stones  are  composed  of
alcium  oxalate  or  calcium  phosphate.49
In  the  second  stage  of  the  analysis,  basal  serum  and
rinary  Ca  before  and  after  dietary  Ca  restriction  in
02  children  >  5  years  were  evaluated.  Serum  Ca  and
 results  were  normal  in  both  groups,  with  no  signif-
cant  differences.  Serum  PTHi  levels  did  not  increase
fter  Ca  restriction  due  to  the  absence  of  hyperparathy-
oidism  (Table  4).  However,  basal  urinary  Ca  assessment
xhibited  46/102  children  (45%)  with  hypercalciuria,  and
7/46  of  them  were  associated  with  hypocitraturia.  After  Ca
estriction  only  20/102  children  (20%)  remained  with  hyper-
alciuria,  and  11  with  hypocitraturia  as  well.  The  ‘‘fasting
rinary  sample’’  exhibited  hypercalciuria  >  0.11  mg/dlGF  in
3/102  of  the  children  (13.0%),  suggesting  an  abnormal  han-
le  of  renal  tubular  calcium  reabsorption.  Nevertheless,
his  group  presented  normocalcemia,  normophosphatemia
nd  PTH  levels  in  serum  were  also  normal.  Therefore,  it
ould  not  be  classiﬁed  as  absorptive,  resorptive  or  renal
orm  of  hypercalciuria.  Levy,  et  al.  termed  this  as  unclas-
iﬁed  hypercalciuria.18 In  this  group,  the  excess  of  PTHi
estores  serum  Ca  to  normal.  Unlike  primary  hyperparathy-
oidism,  calcemia  is  normal  and  the  hyperparathyroidism  is
econdary.17
The  assessment  of  Ca  levels  on  the  restricted  diet
nd  the  post  Ca  load  urine  sample  revealed  high  lev-
ls  of  Ca  (>0.20  mg  urinary  Ca/mg  urinary  creatinine)  in
1/102  patients  (11.0%).  Six  of  them  presented  hypocitra-
uria  as  well,  accompanied  by  normal  Ca  levels  in  the  fasting
rinary  sample  (>0.11  mg/dlGF).  It  was  associated  with  nor-
ocalcemia,  normophosphatemia  and  normal  PTH  levels,
uggestive  of  intestinal  Ca  hyperabsorption.18
Alkaline  urine  (pH  ≥  6.5)  was  observed  in
4/162  children  (21%).  Alkaline  urine  has  been  associ-
ted  with  heterogeneous  causes,  but  are  well  known  as
roteus  sp.  UTI  and  alimentary  disorders.  CaHPO4 urinary
tones  belong  to  an  elevated  urine  pH  as  a  common
eature.50 Acidemia  increases  calcium  phosphatase  release
rom  the  bone  and  reduces  tubular  reabsorption  of  these
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ons.  As  a  consequence,  hypercalciuria  and  hyperphospha-
uria  favor  calcium  stone  formation  and  the  persistence  of
lkaline  urine.50
We  found  33  children  (20%)  with  acidic  urine  (pH  ≤  5.5)
ogether  with  hypocitraturia  and  hypomagnesuria.  Distur-
ances  of  this  system  occur  as  a  reduced  renal  secretion  of
+ ions,  inducing  insufﬁcient  ammonium  with  low  urinary  pH
nd  promoting  uric  acid  stones  formation.50
Systemic  metabolic  acidosis  was  observed  in  33/162  chil-
ren  (20%).  The  main  focus  on  this  disturbance  leading  to
L  is  the  low  urine  pH  with  uric  acid  stones  formation.38,50
ow  urinary  pH  in  human  urine  increases  uric  acid  crystal-
ization  and  subsequent  stone  formation,  even  if  the  uric
cid  excretion  rate  is  normal.38
Distal  renal  tubular  acidosis  (not  analyzed  because  no
rterial  blood  sampling  was  available)  is  linked  to  UL
ecause  acidemia  increases  calcium-phosphate  released
rom  the  bone,  producing  hypercalciuria  and  hyperphospha-
uria,  two  well  known  risk  factors  for  stone  formation.  On
he  other  hand,  metabolic  acidosis  reduces  urinary  excre-
ion  of  citrate,  which  delays  the  crystallization  of  calcium
alts.46,50
Twenty-six  children  (16%)  with  urinary  tract  infection
UTI)  had  metabolic  abnormalities,  and  some  had  congen-
tal  urinary  tract  malformations  (Table  2).  The  frequency
f  UTI  varied  from  10%  to  25%,  similar  to  the  16%  observed
n  previous  reports.51,52 Twelve  children  (12/26)  developed
rease-producing  bacteria  (Proteus  sp,  Haemophilus  sp,
lebsiella  sp  and  Pseudomonas) with  an  alkaline  urine.  Chil-
ren  with  infection  and  stones  have  underlying  metabolic
erangements  that  should  be  evaluated.  Girls  are  signiﬁ-
antly  more  likely  to  experience  UTI  than  boys.53
Urinary  lithiasis  (UL)  with  NC  was  noticed  in  18/162
hildren  (11%).  Their  age  ranged  from  1  to  10  years  with
o  signiﬁcant  gender  differences  (p  <  0.74).  Final  incidence
ates  are  not  available  for  UL,  or  for  NC  in  children28.
rematurity  is  a  special  risk  factor  for  NC29.  Metabolic
isorders  associated  to  UL  and  NC,  such  as  renal  tubular
cidosis,  are  not  uncommon.50 Patients  with  paracellin-1
members  of  the  claudin  family)  defects  develop  hypo-
agnesemia  and  a  striking  incidence  of  hypercalciuria  and
C54.  We  observed  two  children  with  this  biochemical  pro-
le,  but  had  UL  without  NC  (Table  3).  Hyperprostaglandin
 syndrome  is  a  metabolic  alteration  that  causes  hyper-
alciuria  and  NC  by  increasing  the  calcitriol  synthesis55,56;
ent’s  disease57,58,  Lowe  syndrome58,  tyrosinemia  type  159,
artter  syndrome60 and  others  that  we  could  not  identify
linically.  To  distinguishing  between  both  entities  (UL  and
C)  may  be  problematic.  Papillae  endoscopic  inspection  is
etter  to  diagnose  NC.61 Ultrasonography  was  more  sen-
itive  (96%)  than  computed  tomography  (85%)  in  animals
or  NC  diagnosis.62 Other  causes  of  increased  medullary
chogenicity  are  not  clear,  as  the  transient  medullary
yperechogenicity,  or  the  aggregates  of  Tamm-Horsfall
rotein  within  the  renal  calyces  which  may  look  like
ephrocalcinosis.63
Children  are  more  likely  to  have  an  underlying  metabolic
isorder  for  UL/NC  and  a  higher  risk  recurrence,  hence  the
dentiﬁcation  of  metabolic  disorder  is  imperative  to  prevent
tone  recurrence.  Genetic  ﬁndings  with  a  non  Mendelian
ransmission  pattern,  involving  multiple  genes,  suggest  that
ubular  ﬂuid  supersaturation  with  calcium  and  phosphate
c
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redisposes  to  calcium-oxalate  stones  by  triggering  cellular
echanisms  that  lead  to  Randall’s  plaque  formation  on  the
urface  of  the  renal  papillae.14 Up  to  date,  polymorphisms
SNPs)  of  11  genes  were  associated  with  idiopathic  calcium
L  and  NC.14 As  shown  in  table  3,  risk  factor  parameters  in
atients  with  NC  were  similar  to  those  with  UL.  Interestingly,
lbumin  levels  were  under  4  mg/dl  only  in  children  with  UL.
hese  ﬁndings  are  unusual,  but  an  association  with  NL  has
een  reported.39 Two  children  <  3  years  had  hypomagnese-
ia  with  hypercalciuria  and  UL  without  NC.64
As  shown  in  table  2, oliguria  was  found  in  14  children
8.6%).  Children  with  UL  are  known  to  have  low  urine  vol-
mes.  Thus,  children  with  a  ﬁrst  episode  of  UL,  who  were
reated  with  a  high-ﬂuid  intake  for  5  years,  had  a  signif-
cantly  lower  recurrence  rate  than  those  who  received  a
ow-ﬂuid  intake.13
Congenital  urinary  tract  anomalies  were  seen  in  11  chil-
ren  (7%):  four  with  ureteropelvic  stenosis,  two  with  double
reter,  two  with  a duplication  of  the  upper  ureter  with  a  sin-
le  lower  junction,  one  with  unilateral  renal  agenesis,  one
ith  a vesical  septation,  and  one  with  an  anorectal  anomaly.
natomical  abnormalities  and  urinary  tract  infections  are
requently  found  in  most  pediatric  patients  with  UL.
Hypomagnesemia  was  found  in  11  children  (7%)  and
as  associated  with  hypocitraturia  and  hypomagnesuria.64
yperuricosemia  was  observed  in  11  children  (7%),  and
ypercalcemia  in  10  (6%);  all  with  normal  PTHi  values  and
wo  or  more  risk  factors  associated.  Hyperoxaluria  was
bserved  in  three  children  (2%)  without  clinical  evidence  of
ny  metabolic  defect,  two  of  which  had  moderate  inﬂamma-
ory  bowel  disease  history.  Calcium  oxalate  supersaturation
ontributes  to  calcium  stone  formation.
Hypercistinuria  was  observed  in  one  patient  (0.61%),
hich  had  family  history  of  hypercistinuria  and  frequent
rinary  tract  infection  (Table  2).  There  were  no  children
dentiﬁed  with  hyperphosphatemia  or  hyperphosphaturia.
When  the  levels  of  serum  P and  PTH,  and  creatinine  and
 in  urine  from  control  children  were  compared  with  the
ame  parameters  from  patients,  we  found  they  were  similar
nd  normal,  although  statistically  they  disclosed  differences
Table  1).  This  is  unusual;  therefore,  some  authors  make
mphasis  that  not  all  of  the  signiﬁcant  statistic  results  have
linical  relevance.65 None  of  the  children  exhibited  a  single
isk  factor,  but  at  least  two  or  more  risk  factors  for  UL.
In  the  present  prospective  study,  the  incidence  of
L  in  this  pediatric  population  was  0.02%  in  a  5-year
eriod  (2009--2014).  The  median  age  was  7.5  ±  3.9  years.
ale/female  ratio  was  3:1,  and  a  family  history  of  NL  was
ound  in  50%  of  the  children.  Abdominal  pain  was  the  most
ommon  symptom  detected  (52%).  Urinary  tract  stones  were
iagnosed  mainly  by  ultrasonography  (60%).  Pyelocaliceal
ocalization  was  observed  in  52%  of  the  patients.  Anatomic
nd  metabolic  parameters  were  evaluated.  Hypocitraturia
as  the  highest  risk  factor  found  in  70%,  hypomagnesuria
n  43%;  hypercalciuria  in  37%.  After  a  Ca  restriction  diet  in
02  children  >  5  years,  hypercalciuria  was  observed  in  20%.
fter  Ca  diet  followed  by  a Ca  load,  11%  of  the  children
xhibited  intestinal  Ca  hyperabsorption.  Unclassiﬁed  hyper-
alciuria  was  observed  in  children  >  5  years  (13%).  Resorptive
ypercalciuria  and  Ca  renal  leak  were  not  observed.  Alkaline
nd  acid  urine  were  present  in  21%  and  20%,  respec-
ively.  Systemic  metabolic  acidosis  was  observed  in  20%.
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Urinary  infection  was  observed  in  16%  of  the  children.  We
found  18  patients  with  nephrocalcinosis  with  lithiasis  (11%),
and  oliguria  in  8%.  Hypomagnesemia,  hyperuricosemia  and
congenital  urinary  malformation  in  7%  each  one.  Basal
hypercalcemia  was  observed  in  6%,  hyperoxaluria  in  2%  and
hypercystinuria  in  0.61%.  Hyperparathiroidism,  hyperphos-
phaturia,  hiperuricosuria,  or  other  additional  risk  factors
were  not  observed.  All  children  had  two  or  more  risk  factors
for  UL.  This  study  identiﬁes  urolithogenic  factors  that  are
clinically  relevant  for  nephrologists,  urologists,  and  other
physicians.
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